GLP1R and Hypoglycemia: GLP-1 agonists are as effective as insulin at reducing HbA1c, with the additional benefit of weight loss without hypoglycemia, but then a proportion of cases develop nausea and acute pancreatitis is, possibly, an additional, albeit very small, risk [17].